
Ethereum Price Drops 0.6% to $2,365 as Fear & Greed Index Hits Neutral 50
Ethereum price falls 0.6% to $2,365.72 as Fear & Greed Index reaches neutral 50. Bitcoin holds $80,475, signaling stability for web3 startups.
Loading...
Startup ecosystem, funding, and innovation

Michigan Tech launches 4-year AI bachelor's degree in Fall 2026 to tackle 74% harder AI hires in Midwest startups. Local talent cuts $500K costs per role.

Vercel upselling tactics throttle free tiers, pushing web startups to pro plans amid Crypto Fear & Greed Index at 26. BTC hits $76,425 USD, tightening serverless hosting budgets.

A&O Shearman flags surging AI M&A risks in web tech startups amid regulatory scrutiny. BTC reaches $76,363 USD with Fear & Greed Index at 29 signaling investor caution.

White House AI Framework advances US tech leadership but drives Fear & Greed Index to 29. AI startups face 12% funding drop to $15.2B amid compliance fears and policy shifts.

Federated forges like ForgeFed and Tangled counter GitHub's 90% OSS control. Decentralized platforms deliver resilient dev tools for startups facing crypto market volatility.

ElderLawAnswers warns seniors that AI wills from legal AI startups risk court rejection amid Bitcoin's 1.9% drop to $75,741 USD. Crypto volatility and state law gaps threaten estate planning for BTC and ETH holders.

Minnesota lawmakers advance a crypto ATM ban targeting over 100 kiosks linked to senior scams. Bitcoin surges 1.7% to $77,479 amid a Fear & Greed Index at 26, pressuring ATM operators like Bitcoin Depot.

Bitcoin reaches $77,034 on April 28, 2026, up 0.5%. Fear & Greed Index hits 26 amid volatility, while Ethereum climbs 2.1% to $2,324 on ETF inflows.

Laguna XS.2 and M.1 AI e-scooters launched October 10, 2024, target commuters and deliveries. They challenge Uber and Lime with edge AI, direct sales in $100B market.

Hardware startups build custom PCBs with conductive clay in hours via this tutorial, slashing costs amid BTC at $78,247 USD. Accelerates lean prototyping for crypto hardware innovation.

Pharma giants lost $50 billion on Alzheimer's disease trials fixated on amyloid plaques. Startups deploy AI for novel targets amid cautious markets.